[1]翟向伟,高宏勇△,王燕妮,等.冻干重组人脑利钠肽联合替罗非班对急性心肌梗死患者趋化素、半凝乳素-3水平的影响*[J].陕西医学杂志,2020,49(8):995.[doi:DOI:10.3969/j.issn.1000-7377.2020.08.021]
　ZHAI Xiangwei,GAO Hongyong,WANG Yanni,et al.Effect of lyophilized recombinant human brain natriuretic peptide combined with tirofiban on the levels of chemorin and Gal-3 in patients with acute myocardial infarction[J].,2020,49(8):995.[doi:DOI:10.3969/j.issn.1000-7377.2020.08.021]
点击复制

冻干重组人脑利钠肽联合替罗非班对急性心肌梗死患者趋化素、半凝乳素-3水平的影响*

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
49
期数:
2020年8期
页码:
995
栏目:
临床研究
出版日期:
2020-08-05

文章信息/Info

Title:
Effect of lyophilized recombinant human brain natriuretic peptide combined with tirofiban on the levels of chemorin and Gal-3 in patients with acute myocardial infarction
作者:
翟向伟1; 高宏勇2△; 王燕妮3; 白 玲3; 雷新军3
1.陕西省宝鸡市人民医院(宝鸡 721000); 2.西安国际医学中心医院(西安710100)；3.西安交通大学第一附属医院(西安 710061)
Author(s):
ZHAI Xiangwei; GAO Hongyong; WANG Yanni; et al.
Baoji People's Hospital of Shaanxi Provence(Baoji 721000)
关键词:
急性心肌梗死;  治疗;  冻干重组人脑利钠肽;  替罗非班;  趋化素;  半凝乳素-3
Keywords:
Acute myocardial infarction;  Therapy;  Lyophilized recombinant human brain natriuretic peptide;  Tirofiban;  Chemerin;  Gal-3
分类号:
R541.4
DOI:
DOI:10.3969/j.issn.1000-7377.2020.08.021
文献标志码:
A
摘要:
目的:探讨冻干重组人脑利钠肽联合替罗非班对急性心肌梗塞患者趋化素(Chemerin)、半凝乳素-3(Gal-3)水平的影响。方法:选取128例急性心肌梗塞患者为研究对象,依据双色球法随机分为对照组和联合组,各64例。其中对照组患者给予替罗非班治疗,联合组患者给予冻干重组人脑利钠肽联合替罗非班治疗。比较两组患者治疗后的临床疗效和不良反应发生情况,治疗前后的血管内皮功能、血清Chemerin和Gal-3水平及心功能指标。结果:对照组患者治疗后的总有效率为81.25%,联合组患者治疗后的总有效率为98.44%,两组比较的差异具有统计学意义(χ2=10.360,P<0.05)。与对照组相比,联合组患者治疗后NO水平显著升高; ET-1水平显著低降低,组间比较差异有统计学意义(t=9.311,9.346,P<0.05)。联合组患者治疗后Chemerin和Gal-3水平低于对照组,两组比较差异有统计学意义(t=16.906,13.970,P<0.05)。联合组患者治疗后LVEF水平高于对照组,LVEDD水平低于对照组,两组比较差异有统计学意义(t=11.233,7.130,P<0.05)。两组患者治疗后SV和CI比较差异无统计学意义(t=0.772,0.595,P>0.05)。联合组和对照组患者治疗过程中不良反应发生率分别为3.13%和7.81%,两组比较差异无统计学意义(χ2=1.360,P>0.05)。结论:应用冻干重组人脑利钠肽联合替罗非班治疗急性心肌梗塞患者临床效果显著,可显著改善患者的血管内皮功能和心功能,降低Chemerin和Gal-3水平,且安全性较高。
Abstract:
Objective:To investigate the effect of lyophilized recombinant human brain natriuretic peptide(rhBNP)combined with tirofiban on the levels of chemerin and Gal-3 in patients with acute myocardial infarction.Methods:128 patients with acute myocardial infarction were randomly divided into control group and combined group,with 64 cases in each group.The control group was treated with tirofiban,and the combined group was treated with rhBNP and tirofiban.The clinical effect and adverse reactions of the two groups after treatment were compared and analyzed.The vascular endothelial function,the levels of serum chemerin and Gal-3,and the indexes of cardiac function before and after treatment were analyzed.Results:After treatment,the total effective rate of the combined group was 98.44%,which was significantly higher than that of the control group(81.25%)(χ2=10.360,P<0.05); the level of NO in thecombined group was significantly higher than that in the control group,and the level of ET-1 was significantly lower than that in the control group(t=9.311,9.346,P<0.05); the levels of chemorin and Gal-3 in the combined group were significantly lower than those in the control group(t=16.906,13.970,P<0.05); the LVEF in the combined group was significantly higher than that in the control group,and the LVEDD was significantly lower than that in the control group(t=11.233,7.130,P<0.05); there was no significant difference in SV and CI between the two groups(t=0.772,0.595,P>0.05).There was no significant difference in the incidence of adverse reactions between the two groups(χ2=1.360,P>0.05).Conclusion:The clinical effect of rhBNP combined with tirofiban in the treatment of acute myocardial infarction is significant.It can significantly improve the vascular endothelial function and cardiac function of patients,reduce the levels of chemorin and Gal-3,and has high safety.

参考文献/References:

[1] Mahmut Y,Macit K,Mustafa OG,et al.Acute myocardial infarction in a patient suffering from penicillin-induced laryngeal edema:kounis syndrome aggravated by adrenaline[J].Wien Klin Wochenschr,2017,129(7):1-3.
[2] Mariani F,Roncucci L. Chemerin/chemR23 axis in inflammation onset and resolution[J].Inflammation,2015,64(2):85-95.
[3] 李 芳,潘发光,刘 芳.脑梗死患者血清Vaspin、Apelin、Chemerin与颈动脉斑块性质及预后的关系[J].热带医学杂志,2019,19(3):346-349,368.
[4] 刘 海,任 勇,丁星华,等.不同负荷剂量替罗非班对急性ST段抬高型心肌梗死患者经皮冠状动脉介入术相关性心肌损伤与动脉血流情况的影响[J].中国医药,2017,12(2):191-195.
[5] 葛 君,汪朝晖.替罗非班治疗急性ST段抬高型心肌梗死的疗效观察[J].中华全科医学,2014,12(12):2039-2040.
[6] 杨宏飞,鄢高亮.冻干重组人脑利钠肽用于心肌梗死急诊介入术后的近期影响分析[J].安徽医药,2019,23(10):2066-2069.
[7] 杨亚莉,李艳红,刘艳琼,丹参注射液对急性心肌梗死患者炎症因子的影响[J].陕西中医,2015,36(3):282-283.
[8] 刘冬梅,武金玉,戴海鹏,等.RT-3DE评估急性心梗PCI术后左室收缩功能及同步性的临床价值[J].现代生物医学进展,2017,17(7):1364-1367.
[9] 郭 卿,张 晶,李东霞.小剂量替罗非班用于急性非ST段抬高型心肌梗死急诊介入治疗的临床观察[J].中国急救复苏与灾害医学杂志,2012,7(4):315-317,325.
[10] 吴 琼,陈还珍,盖婉丽.重组人脑利钠肽治疗急性心肌梗死合并心力衰竭的效果[J].中国心血管杂志,2019,24(3):250-253.
[11] 汪 磊,洪 飞.重组人脑利钠肽对老年急性失代偿性心力衰竭患者BNP和肾功的影响及疗效研究[J].实用药物与临床,2017,20(12):1388-1391.
[12] 江丽娜,赵翰文,李坤鹏.重组人脑利钠肽与传统药物治疗急性心力衰竭的疗效比较[J].解放军预防医学杂志,2019,37(5):31-32.
[13] 许圆圆,支继新,孙超宇,等.替罗非班联合重组人脑利钠肽治疗急性心肌梗死伴心力衰竭患者的疗效分析[J].中国急救医学,2013,33(4):330-332.
[14] 陈爱军.重组人B型钠尿肽联合替罗非班治疗急性心肌梗死并心力衰竭[J].检验医学与临床,2015,12(10):1407-1408.
[15] 张 翼,祁述善,周胜华,等.血管内皮细胞损伤与急性心肌梗塞[J].中国医师杂志,2003,5(9):1274-1274.
[16] 王聪霞,范雅洁.冠心病血管内皮损伤与血管重构的研究进展[J].西安交通大学学报:医学版,2018,39(4):455-458.
[17] 张梦雨,王 田,孟凡静,等.缺血性心肌病及扩张型心肌病患者血清炎症因子的表达及临床意义探讨[J].中华老年医学杂志,2018,37(11):1185-1189.
[18] 聂 芳,马文涛,徐 新.冻干重组人脑利钠肽对老年急性心梗患者Chemerin、Gal-3水平的影响[J].心血管康复医学杂志,2018,27(5):58-62.
[19] 冯军鹏,梁梅芳,王有恒,等.丹参酮ⅡA磺酸钠联合重组人脑利钠肽治疗心肌梗死的效果、心功能改善情况和预后[J].药物评价研究,2019,42(8):1576-1579.
[20] 韩姗姗,赵翠萍.重组人脑利钠肽在心力衰竭治疗中的研究进展[J].临床药物治疗杂志,2019,17(2):28-31.

相似文献/References:

[1]雷晓敏,曹 蕊△.冠状动脉内注射硝普钠对行经皮冠状动脉介入术〖JZ〗急性心肌梗死患者心血管事件及左室功能的影响研究*[J].陕西医学杂志,2019,(10):1323.
[2]朱志坚,孙丽芳,陆志刚 .外周血中性粒细胞/淋巴细胞比值对急性心肌梗死患者预后的预测价值[J].陕西医学杂志,2019,(10):1326.
　ZHU Zhijian,SUN Lifang,LU Zhigang..Prognostic value of peripheral blood neutrophil/lymphocyte ratio for 〖JZ〗longterm prognosis in patients with acute myocardial infarction[J].,2019,(8):1326.
[3]王 颖,白 琳,张 洁,等.抑制炎性细胞因子与类风湿关节炎合并急性心肌梗死患者颈动脉斑块相关性研究*[J].陕西医学杂志,2019,(12):1679.
[4]贾凯侠,夏旭东△,田 心.体外反搏治疗急性心肌梗死临床疗效及对患者尿微量白蛋白影响研究*[J].陕西医学杂志,2020,49(1):90.
[5]赵 博,王银谦,王红燕.巨噬细胞移动抑制因子与冠心病关系Meta分析[J].陕西医学杂志,2020,49(1):125.
[6]孟 涛,刘锦波,王纪科,等.输尿管硬镜钬激光碎石与后腹腔镜上段输尿管切开取石治疗输尿管结石疗效对比研究*[J].陕西医学杂志,2020,49(2):162.
　MENG Tao,LIU Jinbo,WANG Jike,et al.Analysis of efficacy of holmium laser ureteroscopic lithotripsy and retroperitoneal laparoscopic ureterolithotomy on ureteral calculi[J].,2020,49(8):162.
[7]李延喜,郭世文△.微创手术对高血压基底节脑出血患者生活质量及脑功能恢复效果的影响研究[J].陕西医学杂志,2020,49(2):166.
　LI Yanxi,GUO Shiwen..Effect of minimally invasive surgery on the quality of life and brain function recovery in patients with hypertensive basal ganglia hemorrhage[J].,2020,49(8):166.
[8]谢江涛,苏永永,吴鹏昌,等.显微镜联合神经内镜治疗颅内前循环破裂动脉瘤疗效研究[J].陕西医学杂志,2020,49(2):205.
[9]张静雯,汪 宁,邱红霞,等.非布司他治疗早期糖尿病肾病合并高尿酸血症疗效及对患者肾功能影响研究*[J].陕西医学杂志,2020,49(2):209.
　ZHANG Jingwen,WANG Ning,QIU Hongxia,et al.Efficacy of febuxostat on early diabetic nephropathy with hyperuricemia and its effect on renal function[J].,2020,49(8):209.
[10]姜 萌,赵 鹏△.奥曲肽联合加贝酯治疗重症急性胰腺炎疗效及对患者血清细胞因子水平的影响[J].陕西医学杂志,2020,49(2):212.
　JIANG Meng,ZHAO Peng..Clinical efficacy of octreotide combined with gabexate in the treatment of severe acute pancreatitis and its effect on serum cytokine levels[J].,2020,49(8):212.

备注/Memo

备注/Memo:
*陕西省科技惠民计划项目(2016HM-04)
更新日期/Last Update: 2020-08-04